Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Antibacterial mutilin derivatives

Oct. 1, 1997

Lysostaphin found superior to vancomycin in treating MRSA

Oct. 1, 1997

Clinical results on neuraminidase inhibitor presented at ICAAC

Sep. 30, 1997

Bayer evaluates novel heteroaryl oxazolidinones

Sep. 30, 1997

New class of antifungal agents developed at Glaxo Wellcome

Sep. 30, 1997

PathoGenesis presents new antimycobacterial agents

Sep. 30, 1997

Antiviral thienoxazinones prepared at SKB

Sep. 30, 1997

Zeneca presents new antibacterials active against resistant pathogens

Sep. 30, 1997

Improved oxazolidinone prodrugs reported at ICAAC

Sep. 29, 1997

New oxazolidinone from P&U described at ICAAC

Sep. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...